Embecta Corp

EMBC

Company Profile

  • Business description

    Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

  • Contact

    300 Kimball Drive
    Suite 300
    ParsippanyNJ07054
    USA

    T: +1 862 401-0000

    https://www.embecta.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Instruments & Supplies

    Fiscal Year End

    30 September 2026

    Employees

    1,850

Stocks News & Analysis

stocks

Hostile takeover on the cards for this ASX income opportunity

IFM lobs reasonable takeover offer.
stocks

Get ready for major US tech earnings starting tomorrow morning

Microsoft, Amazon, Alphabet, and Meta will all release quarterly earnings. Here’s what analysts are looking for.
stocks

Corning’s AI fiber boom is real, but its stock price may be getting out of hand

Corning’s optical fiber business is thriving, and the Meta deal derisks its supply buildout, but success isn’t guaranteed.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,915.7016.000.18%
CAC 408,072.1331.96-0.39%
DAX 4023,954.5663.70-0.27%
Dow JONES (US)48,825.78316.15-0.64%
FTSE 10010,213.11119.68-1.16%
HKSE26,111.84432.061.68%
NASDAQ24,609.2554.55-0.22%
Nikkei 22559,917.46619.90-1.02%
NZX 50 Index12,770.305.900.05%
S&P 5007,126.5912.21-0.17%
S&P/ASX 2008,687.009.400.11%
SSE Composite Index4,107.5128.880.71%

Market Movers